These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 27664046)

  • 1. Hypoxia and inflammatory bowel disease.
    Cummins EP; Crean D
    Microbes Infect; 2017 Mar; 19(3):210-221. PubMed ID: 27664046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-sensitive pathways in intestinal inflammation.
    Brown E; Taylor CT
    J Physiol; 2018 Aug; 596(15):2985-2989. PubMed ID: 29114885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of IBD associated diarrhea.
    Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
    Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Inflammatory Hypoxia in the Murine Gut.
    Whitney AK; Campbell EL
    Methods Mol Biol; 2016; 1422():115-26. PubMed ID: 27246027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolome and inflammasome in inflammatory bowel disease.
    Nanau RM; Neuman MG
    Transl Res; 2012 Jul; 160(1):1-28. PubMed ID: 22687960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease.
    Yin J; Ren Y; Yang K; Wang W; Wang T; Xiao W; Yang H
    Cell Biol Int; 2022 Jan; 46(1):46-51. PubMed ID: 34658125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
    Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
    Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tale of two diseases: the history of inflammatory bowel disease.
    Mulder DJ; Noble AJ; Justinich CJ; Duffin JM
    J Crohns Colitis; 2014 May; 8(5):341-8. PubMed ID: 24094598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease.
    Okamoto R; Watanabe M
    J Gastroenterol; 2016 Jan; 51(1):11-21. PubMed ID: 26138071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiopathogenesis of inflammatory bowel diseases.
    Danese S; Fiocchi C
    World J Gastroenterol; 2006 Aug; 12(30):4807-12. PubMed ID: 16937461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of disrupted intestinal barrier in inflammatory bowel diseases.
    Salim SY; Söderholm JD
    Inflamm Bowel Dis; 2011 Jan; 17(1):362-81. PubMed ID: 20725949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.